The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Sep 01, 2026
Snapshot (as of Sep 01, 2026): Medtronic plc (MDT) pays a $2.85 annual dividend ($0.72 quarterly), yielding 3.08% at $92.46/share. Next ex-dividend date 2026-09-25. 7 consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 3.08%
Annual Dividend: $2.85 per share
Payout Ratio: 69.8%
Ex-Dividend Date: 2026-09-25
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 45
Medtronic plc dividend investors are looking at a company that manufactures pacemakers, insulin pumps, surgical robotics, and spinal imaging systems sold to healthcare systems worldwide. The current yield is 3.05%, with a trailing annual dividend rate of $2.85 per share paid quarterly. The next ex-dividend date is September 25, 2026. A beta of 0.566 means MDT stock moves at roughly half the volatility of the broader market, which suits income investors who prioritize price stability alongside yield.
Medtronic plc pays out 75.8% of earnings as dividends, a payout ratio classified as high (above 75%). That level is supported by demand for the company's device-based therapies, including implantable cardiac devices, continuous glucose monitors, and robotic surgical platforms, which serve clinicians and healthcare systems with ongoing clinical needs. Medtronic plc dividend safety faces its main pressure from that elevated payout ratio, which leaves limited room to absorb earnings weakness without affecting the dividend.
Medtronic plc dividend history shows a CAGR of 8.3% per year from 2010 to 2025. The per-share annual dividend grew from $0.86 to $2.83 over that period (2026 is a partial year and excluded from the growth calculation). The largest annual increase in the window was 35.3% in 2012, though the data also contains at least one year-over-year decline exceeding 5%, so growth has not been linear.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +2.0% | $2.67 (2022) | $2.83 (2025) |
| 5-Year | +4.4% | $2.28 (2020) | $2.83 (2025) |
| 10-Year | +7.0% | $1.45 (2015) | $2.83 (2025) |
MDT fits dividend investors who want a moderate yield from a business with broad, recurring clinical demand. The current yield of 3.05% sits above the 5-year average of 2.89%, meaning the stock currently offers slightly more income than its own historical norm. The trade-off is a payout ratio of 75.8%, which is high and limits how aggressively MDT can grow the dividend from here. The yield classification is moderate (2–4%), and with seven consecutive years of increases, the payment has been growing, just not at a pace that dramatically compounds income over short periods. What an investor gets is a lower-volatility healthcare stock with a yield above its own average; what they accept is a payout structure that leaves little financial cushion.
| Payment Date | Amount per Share |
|---|---|
| 2026-09-25 | $0.7200 |
| 2026-06-26 | $0.7200 |
| 2026-03-27 | $0.7100 |
| 2025-12-26 | $0.7100 |
| 2025-09-26 | $0.7100 |
| 2025-06-27 | $0.7100 |
| 2025-03-28 | $0.7000 |
| 2024-12-27 | $0.7000 |
| 2024-09-27 | $0.7000 |
| 2024-06-28 | $0.7000 |
| Year | Total Dividends |
|---|---|
| 2026 | $2.1500 |
| 2025 | $2.8300 |
| 2024 | $2.7900 |
| 2023 | $2.7500 |
| 2022 | $2.6700 |
Project income from MDT with the MDT dividend calculator or track your full portfolio with the dividend tracker.